Literature DB >> 7591556

Cost-effectiveness studies of renal transplantation.

I Karlberg1, G Nyberg.   

Abstract

This study analyzes opportunity costs for the treatment of end-stage renal disease. Kidney transplantation remains the most cost-effective treatment for uremia and is one of the most cost-effective technologies in health care. Improved survival of grafts and increased numbers of transplants have the potential to reduce costs for dialysis programs. To support organ donation activities, the public and concerned health professionals should be informed about the opportunity cost of "unnecessary" dialysis. These resources could be reallocated from dialysis to other programs. Among patients in dialysis, a more common use of chronic ambulatory peritoneal dialysis instead of institution-based hemodialysis would greatly increase cost-utility and further reduce the program costs of renal replacement therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7591556     DOI: 10.1017/s026646230000876x

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  18 in total

Review 1.  Incentives for organ donation: proposed standards for an internationally acceptable system.

Authors:  Arthur J Matas; Sally Satel; Stephen Munn; Janet Radcliffe Richards; Angeles Tan-Alora; Frederike J A E Ambagtsheer; Micheal D H Asis; Leo Baloloy; Edward Cole; Jeff Crippin; David Cronin; Abdallah S Daar; James Eason; Richard Fine; Sander Florman; Richard Freeman; John Fung; Wulf Gaertner; Robert Gaston; Nasrollah Ghahramani; Ahad Ghods; Michelle Goodwin; Thomas Gutmann; Nadey Hakim; Benjamin Hippen; Ajit Huilgol; Igal Kam; Arlene Lamban; Walter Land; Alan Langnas; Reynaldo Lesaca; Gary Levy; RoseMarie Liquette; William H Marks; Charles Miller; Enrique Ona; Glenda Pamugas; Antonio Paraiso; Thomas G Peters; David Price; Gurch Randhawa; Alan Reed; Keith Rigg; Dennis Serrano; Hans Sollinger; Sankaran Sundar; Lewis Teperman; Gert van Dijk; Willem Weimar; Romina Danguilan
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

Review 2.  Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

Authors:  Melissa Young; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective.

Authors:  Stephen J Walters; Malcolm Whitfield; Ronald L Akehurst; James B Chilcott
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Aspects of quality of life through end-stage renal disease.

Authors:  Gabriele Helga Franke; Jens Reimer; Thomas Philipp; Uwe Heemann
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

5.  The costs in provision of haemodialysis in a developing country: a multi-centered study.

Authors:  Priyanga Ranasinghe; Yashasvi S Perera; Mohamed F M Makarim; Aruna Wijesinghe; Kamani Wanigasuriya
Journal:  BMC Nephrol       Date:  2011-09-06       Impact factor: 2.388

6.  Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.

Authors:  Germaine Wong; Kirsten Howard; Jeremy R Chapman; Steven Chadban; Nicholas Cross; Allison Tong; Angela C Webster; Jonathan C Craig
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

7.  Five years allograft survival of renal transplants: a single center study.

Authors:  E Ghanei; M R Razaghi; M Homayouni
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

8.  Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis.

Authors:  Tapani Salonen; Tuomo Reina; Heikki Oksa; Pekka Rissanen; Amos Pasternack
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.266

9.  Transperitoneal laparoscopic live donor nephrectomy: Current status.

Authors:  A Srivastava; N Gupta; Anant Kumar; Rakesh Kapoor; Deepak Dubey
Journal:  Indian J Urol       Date:  2007-07

10.  Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?

Authors:  Jamshid Salamzadeh; Naghmeh Foroutan; Hamid Reza Jamshidi; Hamid Reza Rasekh; Ali Rajabzadeh Gatari; Arash Foroutan; Mohsen Nafar
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.